Don’t wait until you develop Alzheimer’s disease – prevent it! On June 7th, 2021, the American Food and Drug Administration (FDA) “conditionally” approved Aducanumab (Aduhelm), an amyloid beta-directed monoclonal antibody which treats Alzheimer’s disease by removing BetaAmyloid from the brain. Aducanumab is the first new Alzheimer’s drug since 2003, and the first potentially disease-modifying agent. Aducanumab treatment costs US $65,000 per year. The approval is surprising, because: (1) Of (only) two trials, one showed no benefit from the drug.(2) One third of drug recipients developed brain swelling and other side effects.(3) Only 9% of patients’ Alzheimer’s improved. (4) The drug…
-
-
This website is a free medical information source for my old patients and anyone who needs info about hormones. I don’t want to put annoying, indiscriminate ads on the site, I have nothing to sell and I don’t want to ask for a subscription. Perhaps I could run ads for helpful things which I consider worthwhile, like vitamins, essential minerals, healthcare appliances etc, but I don’t know the best way to approach manufacturers [so that I get a fair fee for allowing the ads onto my site]. If any of you can offer advice on this subject, please join up…
You must be logged in to post a comment.